| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00000658-200308000-00007 |
| 10.1097/01.SLA.0000080822.22415.CB | ||
| P932 | PMC publication ID | 1422696 |
| P698 | PubMed publication ID | 12894012 |
| P2093 | author name string | Masanori Ikeda | |
| Shoji Natsugoe | |||
| Takashi Aikou | |||
| Shinichi Ueno | |||
| Masamichi Baba | |||
| P2860 | cites work | DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES | Q24679675 |
| A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma | Q28187716 | ||
| Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer | Q33891557 | ||
| Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma | Q35358588 | ||
| In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis | Q36292075 | ||
| Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate | Q36620446 | ||
| Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma | Q40808781 | ||
| Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia | Q41719391 | ||
| Cytokine mRNA expression patterns in human esophageal cancer cell lines | Q42811010 | ||
| Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas | Q44425082 | ||
| The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer. | Q47272589 | ||
| Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World | Q58484706 | ||
| A new immuno quantitative method by latex agglutination--application for the determination of serum C-reactive protein (CRP) and its clinical significance | Q68866754 | ||
| Detection of androgen receptors in human esophageal cancer | Q69616099 | ||
| The oxidation of body fuel stores in cancer patients | Q69683369 | ||
| Ultrasonic detection of lymph node metastases in the region around the celiac axis in esophageal and gastric cancer | Q69940838 | ||
| [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients] | Q70507813 | ||
| Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation | Q70708963 | ||
| Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma | Q71148424 | ||
| Ultrasonographic detection of lymph-node metastases in superficial carcinoma of the esophagus | Q71813433 | ||
| Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus | Q72339365 | ||
| [Expression and significance of immunosuppressive acidic protein (IAP) in human esophageal squamous cell carcinoma] | Q72714375 | ||
| Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma | Q74561303 | ||
| Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma | Q77089943 | ||
| Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information | Q77557263 | ||
| Assessment of cervical lymph node metastasis in esophageal carcinoma using ultrasonography | Q77922693 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 197-202 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma | |
| P478 | volume | 238 |
| Q34352751 | A new inflammation index is useful for patients with esophageal squamous cell carcinoma |
| Q36614306 | An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. |
| Q37152934 | An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. |
| Q35071202 | Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study |
| Q84949800 | Association of C-reactive protein levels and long-term survival after neoadjuvant therapy and esophagectomy for esophageal cancer |
| Q26771557 | C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review |
| Q36449810 | Changes of acute-phase protein levels in the serum of lung cancer patients following radiotherapy |
| Q34346758 | Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer |
| Q64946952 | Combined Chemoradiotherapy-induced Weight Loss Decreases Survival in Locally Advanced Non-small Cell Lung Cancer Patients. |
| Q36695064 | Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer |
| Q82863073 | Comparison of pre-treatment clinical prognostic factors in patients with gastro-oesophageal cancer and proposal of a new staging system |
| Q84021198 | Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer |
| Q39711957 | Decreased expression of CIAPIN1 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma |
| Q46372296 | Elevated C-reactive protein as a predictor of patient outcomes following palliative surgery |
| Q64063991 | Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients |
| Q82215547 | Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL‐6 in serum and local tumor site in patients with advanced esophageal cancer |
| Q36610116 | Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. |
| Q53319774 | Expression and prognostic value of ZNRD1 in esophageal squamous cell carcinoma. |
| Q26741107 | Feeding Challenges in Patients with Esophageal and Gastroesophageal Cancers |
| Q40822344 | High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib. |
| Q44781751 | Immunohistochemical evaluation for P53 and VEGF (Vascular Endothelial Growth Factor) is not prognostic for long term survival in end stage esophageal adenocarcinoma |
| Q83189169 | Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy |
| Q40381673 | Interleukin-8 producing hepatocellular carcinoma with pyrexia |
| Q47958907 | Nutritional risk factors in planned oncologic surgery: what clinical and biological parameters should be routinely used? |
| Q37548324 | Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL study |
| Q80086020 | Pre-operative nutritional status does not alter the metabolic response to major gastrointestinal surgery in patients with oesophageal cancer |
| Q46976300 | Pre-operative predictive factors of early recurrence after resection of adenocarcinoma of the esophagus and cardia |
| Q52888642 | Preoperative Plasma Fibrinogen is Associated with Lymph Node Metastasis and Predicts Prognosis in Resectable Esophageal Cancer. |
| Q90166775 | Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis |
| Q84790760 | Prognostic Factors and Family History for Survival of Esophageal Squamous Cell Carcinoma Patients After Surgery |
| Q45233598 | Prognostic factors in patients with gemcitabine-refractory pancreatic cancer |
| Q38344796 | Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis |
| Q35202177 | Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review |
| Q43077762 | Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer |
| Q50050115 | Prognostic value of metabolic volume measured by F-18 FDG PET-CT in patients with esophageal cancer |
| Q44040524 | Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer |
| Q34133427 | Proposed follow up programme after curative resection for lower third oesophageal cancer |
| Q42180630 | Risk factors for postoperative respiratory complications following esophageal cancer resection |
| Q40359356 | Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer |
| Q46767182 | Scoring system for predicting response to chemoradiotherapy, including 5-Fluorouracil and platinum, for patients with esophageal cancer |
| Q33866407 | Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus |
| Q35037270 | Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer |
| Q36615780 | Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. |
| Q35458918 | The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis |
| Q51071190 | The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment. |
| Q36612383 | The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer |
| Q36616232 | The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. |
| Q36611805 | The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder. |
| Q35879893 | The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma |
| Q46117374 | The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer |
| Q52928949 | Thrombocytosis and Raised CRP Levels Predicts Advanced Stage in Esophageal Carcinoma. |
| Q41919033 | Time course of serum C-reactive protein levels during induction chemoradiotherapy and its correlation with treatment response and survival in patients with advanced esophageal squamous cell carcinoma |
| Q84684425 | Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients |
| Q41616674 | Validation of a new approach for mortality risk assessment in oesophagectomy for cancer based on age- and gender-corrected body mass index. |
Search more.